Reuters logo
BRIEF-Spectrum Pharmaceuticals reports Q4 loss per share of $0.22
March 8, 2017 / 9:21 PM / 9 months ago

BRIEF-Spectrum Pharmaceuticals reports Q4 loss per share of $0.22

March 8 (Reuters) - Spectrum Pharmaceuticals Inc

* Spectrum Pharmaceuticals reports fourth quarter 2016 and full year 2016 financial results and pipeline update

* Q4 non-GAAP loss per share $0.10

* Q4 loss per share $0.22

* Q4 revenue $35.2 million versus I/B/E/S view $31.1 million

* Q4 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

* Says Rolontis(eflapegrastim) pivotal program is on track for spectrum to file BLA next year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below